Back to search
FDAFDA · Food and drugs·Recall number D-0713-2022

Dexamethasone Elixir, USP 0.5 mg/5 mL, Net: 8 fl oz (237 mL) bottle, Rx only, Manufactured By: Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053, NDC 60432-466-08.

Published March 9, 2022 · Recall initiated: February 21, 2022

Summary

FDA records drug Class II recall D-0713-2022, published March 9, 2022 and initiated February 21, 2022. Recalling firm: Morton Grove Pharmaceuticals, Inc.; Status: Terminated; Lot: Lot #s: UV1004, UV1005, Exp 6/22; UW1014, UW1015, Exp 1/23; UW1084, Exp 7/23. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: higher than permissible levels of unknown impurities were found in the drug product.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Morton Grove Pharmaceuticals, Inc.
Distributor
Nationwide USA and Puerto Rico
Lot
Lot #s: UV1004, UV1005, Exp 6/22; UW1014, UW1015, Exp 1/23; UW1084, Exp 7/23
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dexamethasone Elixir, USP 0.5 mg/5 mL, Net: 8 fl oz (237 mL) bottle, Rx only, Manufactured By: Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053, NDC 60432-466-08. recalled?

Yes. FDA published recall D-0713-2022 on March 9, 2022. Reported hazard: Failed Impurities/Degradation Specifications: higher than permissible levels of unknown impurities were found in the drug product.

What should I do if I have this product?

Voluntary: Firm initiated · Letter